We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
+6.87%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$249M
AUM Growth
–
Cap. Flow
+$253M
Cap. Flow
% of AUM
101.64%
Top 10 Holdings %
Top 10 Hldgs %
23.86%
Holding
125
New
124
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TECD
Tech Data Corp
TECD
|
+$15.4M |
| 2 |
Bausch Health
BHC
|
+$6.96M |
| 3 |
JetBlue
JBLU
|
+$6.91M |
| 4 |
AAWW
Atlas Air Worldwide Holdings, Inc.
AAWW
|
+$5.9M |
| 5 |
Raymond James Financial
RJF
|
+$5.72M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Industrials | 16.39% |
| 3 | Consumer Discretionary | 12.92% |
| 4 | Materials | 12.06% |
| 5 | Healthcare | 9.66% |
Similar funds
SIG
CAG
ORCP
ET
GC
MIAS
TAL
IIP
Invenomic Capital Management's Q4 2019 Portfolio in Review
Q4 2019 is the first quarter with a 13F filing on record for Invenomic Capital Management, which disclosed 125 positions worth $249M. Its ten largest holdings account for 24% of the portfolio.
Its largest position is Tech Data Corp: 119,657 shares worth $1.43M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, followed by Industrials and Consumer Discretionary.
- Invenomic Capital Management's largest Q4 2019 buy was Tech Data Corp: 119,657 shares worth $1.43M.
- Invenomic Capital Management's ten largest holdings make up 24% of its $249M portfolio in Q4 2019.
- Invenomic Capital Management disclosed 125 positions in Q4 2019, its first 13F filing on record.
Based on Invenomic Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.